Executive at NATIONAL HEALTHCARE (NHC) receives 14,000-share stock option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NATIONAL HEALTHCARE CORP reported that Senior VP & General Counsel Josh A. McCreary received a grant of stock options to purchase 14,000 shares of common stock on February 23, 2026, at an exercise price of $0.00 per share.
The options were granted under the 2020 Omnibus Equity Incentive Plan and will vest in three equal parts: one-third on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. The grant is described as exempt from Section 16(b) under Rule 16b-3(d).
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
McCreary Josh A
Role
Senior VP & General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to Purchase Common Stock | 14,000 | $0.00 | -- |
| holding | Option to Purchase Common Stock | -- | -- | -- |
| holding | Option to Purchase Common Stock | -- | -- | -- |
| holding | Option to Purchase Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Option to Purchase Common Stock — 14,000 shares (Direct);
Common Stock — 9,942 shares (Direct)
Footnotes (1)
- These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.
FAQ
What insider transaction did NHC report for Josh A. McCreary?
NHC reported that Senior VP & General Counsel Josh A. McCreary received a grant of options to purchase 14,000 shares of common stock. The options were granted on February 23, 2026, under the 2020 Omnibus Equity Incentive Plan at an exercise price of $0.00 per share.
How do the new NHC stock options for Josh A. McCreary vest?
The 14,000 NHC stock options granted to Josh A. McCreary vest ratably over three years. One-third vests on February 23, 2027, another third on February 23, 2028, and the final third on February 23, 2029, before becoming exercisable according to the plan terms.
Under what plan were Josh A. McCreary’s NHC options granted?
Josh A. McCreary’s options to purchase 14,000 NHC common shares were granted under the 2020 Omnibus Equity Incentive Plan. This plan provides for equity-based awards to eligible participants as part of the company’s compensation and incentive structure for executives and other key personnel.
Is the NHC option grant to Josh A. McCreary exempt from Section 16(b)?
Yes. The filing states that the grant and potential exercise of these NHC stock options are exempt from Section 16(b) under Rule 16b-3(d). This exemption generally applies to properly approved insider equity awards made under qualifying compensation arrangements.
Did the Form 4 show any open-market buying or selling of NHC common stock?
The Form 4 highlights a grant of options to purchase 14,000 NHC shares rather than open-market trades. It also lists updated holdings, including 9,942 shares of common stock held directly, but does not indicate separate buy or sell transactions in the common stock in this filing.
What is Josh A. McCreary’s role at NHC mentioned in the Form 4?
The Form 4 identifies Josh A. McCreary as Senior Vice President and General Counsel of NHC. This executive role typically covers the company’s legal affairs, governance matters, and coordination of compliance with securities regulations, including reporting of insider equity awards like this option grant.